Regulatory T Cells in the Pathogenesis of Graves’ Disease
International Journal of Molecular Sciences · 17.11.2023 · 24 (22) · 16432
DOI: 10.3390/ijms242216432 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.11.2023. Verfasst von Natasa Kustrimovic und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Research on Autoimmune and Allergic Disease-CAAD, Università del Piemonte Orientale, 28100 Novara, Italy. Hauptthemen laut MEDLINE: Graves Disease, Hashimoto Disease. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondi di Ateneo per la Ricerca, University of Insubria.
Abstract (Originalsprache)
Maintaining a delicate balance between the prompt immune response to pathogens and tolerance towards self-antigens and commensals is crucial for health. T regulatory (Treg) cells are pivotal in preserving self-tolerance, serving as negative regulators of inflammation through the secretion of anti-inflammatory cytokines, interleukin-2 neutralization, and direct suppression of effector T cells. Graves’ disease (GD) is a thyroid-specific autoimmune disorder primarily attributed to the breakdown of tolerance to the thyroid-stimulating hormone receptor. Given the limitations of currently available GD treatments, identifying potential pathogenetic factors for pharmacological targeting is of paramount importance. Both functional impairment and frequency reduction of Tregs seem likely in GD pathogenesis. Genome-wide association studies in GD have identified polymorphisms of genes involved in Tregs’ functions, such as CD25 (interleukin 2 receptor), and Forkhead box protein P3 (FOXP3). Clinical studies have reported both functional impairment and a reduction in Treg frequency or suppressive actions in GD, although their precise involvement remains a subject of debate. This review begins with an overview of Treg phenotype and functions, subsequently delves into the pathophysiology of GD and into the existing literature concerning the role of Tregs and the balance between Tregs and T helper 17 cells in GD, and finally explores the ongoing studies on target therapies for GD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Translational Research on Autoimmune and Allergic Disease-CAAD, Università del Piemonte Orientale, 28100 Novara, Italy.
- Endocrine Unit, Department of Medicine and Surgery, University of Insubria, ASST dei Sette Laghi, 21100 Varese, Italy.
- Dermatology Unit, Department of Medicine and Surgery, University of Insubria, ASST dei Sette Laghi, 21100 Varese, Italy.
- Immunology and General Pathology Laboratory, Department of Biotechnology and Life Sciences, University of Insubria, 21100 Varese, Italy.
ORCID-Profile: Natasa Kustrimovic, Daniela Gallo, Maria Laura Tanda, Lorenzo Mortara
Förderung
- Fondi di Ateneo per la Ricerca
- University of Insubria
Zitieren
APA
Kustrimovic, N., Gallo, D., Piantanida, E., Bartalena, L., Lai, A., Zerbinati, N., Tanda, M. L., & Mortara, L. (2023). Regulatory T Cells in the Pathogenesis of Graves’ Disease. International Journal of Molecular Sciences, 24(22), 16432. https://doi.org/10.3390/ijms242216432
Vancouver
Kustrimovic N, Gallo D, Piantanida E, Bartalena L, Lai A, Zerbinati N, et al. Regulatory T Cells in the Pathogenesis of Graves’ Disease. International Journal of Molecular Sciences. 2023;24(22):16432. doi:10.3390/ijms242216432
BibTeX
@article{Kustrimovic2023,
author = {Kustrimovic, Natasa and Gallo, Daniela and Piantanida, Eliana and Bartalena, Luigi and Lai, Adriana and Zerbinati, Nicola and Tanda, Maria Laura and Mortara, Lorenzo},
title = {Regulatory T Cells in the Pathogenesis of Graves’ Disease},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {22},
pages = {16432},
doi = {10.3390/ijms242216432}
}
EUVIMED